Q1 2027 Insecticides (India) Ltd Earnings Call Transcript
Key Points
- Premium product portfolio (Maharatna and Focus Maharatna) contribution increased to 64% of B2C sales, up from 58% in the same quarter last year, reflecting successful premiumization strategy.
- Gross profit margin expanded by 240 basis points year-over-year to 31.6%, driven by a better product mix and strategic pricing.
- Launched two new co-branded products (Granuvia and Spinos Ace) with Corteva Agrifiscience, which are expected to generate combined net sales of approximately 25 crores in FY27.
- Strong farmer engagement initiatives, including over 3,600 farmer meetings, 600 field days, and 1,400 demonstrations, supported by a network of 8,500 distributors and 70,000 retailers.
- International business is gaining momentum with new registrations and partnerships in Latin America and ASEAN, and the company is expanding its technical product exports, which are receiving good global acceptance.
- The company is nearing the end of its heavy investment cycle, with annual CapEx expected to normalize to INR 30-40 crores, allowing for increased focus on cash generation and operational leverage.
- The product pipeline is robust, with more than 30 products slated for launch over the next two years, supported by internal R&D and collaborations with partners like Nissan and OT Agrio.
- Revenue growth was minimal at 1% year-over-year, impacted by a delayed and uneven monsoon and high temperatures that suppressed demand for crop protection products.
- EBITDA margin declined significantly from 12.2% to 9.1%, and net profit margin fell from 8.4% to 7.3% due to lower volumes and higher input costs.
- Sales of generic products declined sharply, with revenue from generic products dropping from INR 97 crores to INR 74 crores, and contribution from combination products falling from INR 134 crores to INR 98 crores.
- The company faced significant raw material price volatility, particularly in solvents, plastics, and emulsifiers, with price fluctuations of 25-50% week-to-week, making cost management challenging.
- Inventory levels were slightly elevated due to the slower start of the agricultural season, and the company had to roll back a planned price hike in May due to weak market sentiment.
- The B2C segment's share of total sales fell to 64% from 75% last year, while B2B grew to 34%, indicating a shift in the sales mix that may carry different margin profiles.
- The new subsidiary, Kyros, is currently operating at single-digit margins and is expected to remain so until it scales, with high initial expenses including hiring 100 new employees.
Ladies and Gentlemen, Good day and welcome to Insecticides India Limited Q1FR27 Earnings Conference Call.
As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing then 0 on your touchstone phone.
Please note that this conference has been recorded. I now hand the conference over to Ms. Sejal Bhattar from MMFG in time.
Thank you and over to you ma'am.
Thank you and welcome to Q1 and 3 months FY27 earnings call of Insecticides India Limited. Today on this call we have with us Mr. Rajesh Kumar Agarwal, Managing Director, Mr. Sandeep Aggarwal, Chief Financial Officer; Mr. Devendra Kumar Ray, Chief Operating Officer; and Mr. Dushyant Sood, Chief Marketing Officer. Before we proceed with the call, I would like to give a small disclaimer that this conference may contain certain
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
